RNF220 and acute myeloid leukemia: To investigate the relationship between RNF220 and the tumor immune microenvironment, we first employed the xCELL algorithm to analyze RNA-seq data from AML and ALL patients in the TCGA and TARGET cohorts, assessing correlations between RNF220 expression and immune cell subtype proportions.